Pfizer Financials
| PFE Stock | EUR 25.92 0.08 0.31% |
Pfizer |
Please note, the presentation of Pfizer's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Pfizer's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Pfizer's management manipulating its earnings.
You should never invest in Pfizer without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Pfizer Stock, because this is throwing your money away. Analyzing the key information contained in Pfizer's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Pfizer Key Financial Ratios
Pfizer's financial ratios allow both analysts and investors to convert raw data from Pfizer's financial statements into concise, actionable information that can be used to evaluate the performance of Pfizer over time and compare it to other companies across industries.Pfizer Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Pfizer's current stock value. Our valuation model uses many indicators to compare Pfizer value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Pfizer competition to find correlations between indicators driving Pfizer's intrinsic value. More Info.Pfizer Inc is rated top company in current valuation category among its peers. It also is considered to be number one stock in price to book category among its peers . The ratio of Current Valuation to Price To Book for Pfizer Inc is about 90,844,351,534 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Pfizer by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Pfizer's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Pfizer Inc Systematic Risk
Pfizer's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Pfizer volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was five with a total number of output elements of fifty-six. The Beta measures systematic risk based on how returns on Pfizer Inc correlated with the market. If Beta is less than 0 Pfizer generally moves in the opposite direction as compared to the market. If Pfizer Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Pfizer Inc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Pfizer is generally in the same direction as the market. If Beta > 1 Pfizer moves generally in the same direction as, but more than the movement of the benchmark.
Pfizer January 6, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Pfizer help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Pfizer Inc. We use our internally-developed statistical techniques to arrive at the intrinsic value of Pfizer Inc based on widely used predictive technical indicators. In general, we focus on analyzing Pfizer Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Pfizer's daily price indicators and compare them against related drivers.
| Downside Deviation | 1.53 | |||
| Information Ratio | (0) | |||
| Maximum Drawdown | 10.19 | |||
| Value At Risk | (1.84) | |||
| Potential Upside | 2.38 |
Complementary Tools for Pfizer Stock analysis
When running Pfizer's price analysis, check to measure Pfizer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pfizer is operating at the current time. Most of Pfizer's value examination focuses on studying past and present price action to predict the probability of Pfizer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pfizer's price. Additionally, you may evaluate how the addition of Pfizer to your portfolios can decrease your overall portfolio volatility.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |